XRF Scientific (ASX:XRF) ROCE %: 23.66% (As of Dec. 2025)


ASX:XRF XRF Scientific Ltd ASX:XRF
99 GF Score
Price A$1.79
GF Value A$1.65
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is XRF Scientific ROCE %?

XRF Scientific ASX:XRF -5.05% 99 ROCE % is 23.66% as of Dec. 2025. GuruFocus rates ASX:XRF with a GF Score™ of 99/100 and a GF Value™ of A$1.65 (Fairly Valued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. XRF Scientific's annualized ROCE % for the quarter that ended in Dec. 2025 was 23.66%.

XRF Scientific  (ASX:XRF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

XRF Scientific ROCE % Related Terms

XRF Scientific ROCE % Historical Data

* Premium members only.

The historical data trend for XRF Scientific's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XRF Scientific ROCE % Chart

XRF Scientific Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.64 19.25 22.92 23.56 24.53

XRF Scientific Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.05 26.13 24.58 26.07 23.66
ASX:XRF
99GF Score
XRF Scientific Ltd ASX:XRF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XRF Scientific ROCE % Calculation

XRF Scientific's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=14.847/( ( (68.233 - 10.45) + (72.786 - 9.536) )/ 2 )
=14.847/( (57.783+63.25)/ 2 )
=14.847/60.5165
=24.53 %

XRF Scientific's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=15.072/( ( (72.786 - 9.536) + (70.032 - 5.891) )/ 2 )
=15.072/( ( 63.25 + 64.141 )/ 2 )
=15.072/63.6955
=23.66 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 23.66% mean?
XRF Scientific (ASX:XRF) has a ROCE % of 23.66% as of Dec. 2025.
Is XRF Scientific's ROCE % too high?
XRF Scientific's current ROCE % is 23.66%. The Conglomerates industry median ROCE % is 6.92. XRF Scientific's value of 23.66% is 241.9% above this industry median. Overall, XRF Scientific has a GF Score™ of 99/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's ROCE % compare to HON and MMM?
XRF Scientific's ROCE % of 23.66% can be compared against companies in the Conglomerates industry. The industry median ROCE % is 6.92. XRF Scientific's value of 23.66% is 241.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Conglomerates company?
The median ROCE % among Conglomerates companies is 6.92, based on 556 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. XRF Scientific's current ROCE % of 23.66% is 241.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Conglomerates industry, the median ROCE % is 6.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XRF Scientific's current ROCE % is 23.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.65, compared to a current price of A$1.79 — trading 8.2% above its estimated fair value. The current ROCE % is 23.66% and 241.9% above the Conglomerates industry median of 6.92. XRF Scientific's overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current ROCE % is 23.66% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is XRF Scientific (ASX:XRF) Overvalued in 2026?

Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued. The current stock price of A$1.79 is trading 8.2% above its estimated GF Value™ of A$1.65. GuruFocus considers XRF Scientific to be Fairly Valued.

Key valuation signals for ASX:XRF:

  • ROCE %: 23.66%
  • GF Value™: A$1.65 vs. price of A$1.79 (8.2% above fair value)
  • GF Score™: 99/100 with 1 warning sign
  • Industry Position: 241.9% above the Conglomerates median

No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

XRF Scientific Business Description

Address 86 Guthrie Street, Osborne Park, Perth, WA, AUS, 6017
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
99GF Score

Get the complete analysis for ASX:XRF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.79
Price
A$1.65
GF Value